Analysis: A look at why Prozac is only antidepressant OK'd for youths

09/21/2004 | NYTimes.com

In the wake of an FDA advisory committee recommendation calling for warnings on antidepressants meant for children, Eli Lilly's Prozac remains the only FDA-approved treatment for pediatric depression, even though experts say it is functionally no different than its competitors. It may be different in chemical terms, but it works on the same principle, the experts say, and it has not been proven safer or more effective than competing antidepressants. A medical adviser to Eli Lilly said "the drug is safe and effective in children."

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park